期刊
ONCOTARGET
卷 7, 期 25, 页码 38959-38972出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.8341
关键词
metabolic syndrome; cancer risk; visceral adiposity; hyperglycemia; inflammation
资金
- Italian Ministry of Research (PRIN grant)
- RSA
- University of Marche
Metabolic syndrome is a cluster of risk factors that lead to cardiovascular morbidity and mortality. Recent studies linked metabolic syndrome and several types of cancer. Although metabolic syndrome may not necessarily cause cancer, it is linked to poorer cancer outcomes including increased risk of recurrence and overall mortality. This review tends to discuss the major biological and physiological alterations involved in the increase of incidence and mortality of cancer patients affected by metabolic syndrome. We focus on metabolic syndrome-associated visceral adiposity, hyperinsulinemia, hyperglycemia, insulin-like growth factor (IGF-I) pathway as well as estrogen signaling and inflammation. Several of these factors are also involved in carcinogenesis and cancer progression. A better understanding of the link between metabolic syndrome and cancer may provide new insight about oncogenesis. Moreover, prevention of metabolic syndrome-related alterations may be an important aspect in the management of cancer patients during simultaneous palliative care.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据